Research graph
References from Prevalence of Anxiety and Depressive Symptoms among Patients with Lymphoma before and during Chemotherapy: A Cross-sectional Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Anxiety and depression in adult cancer patients: ESMO clinical practice guideline
10.1016/j.esmoop.2023.101155 · 2023 · External reference
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies
10.1016/s1470-2045(11)70002-x · 2011 · External reference
Global prevalence and determinant factors of pain, depression, and anxiety among cancer patients: An umbrella review of systematic reviews and meta-analyses
10.1186/s12888-025-06599-5 · 2025 · External reference
Anxiety and depression among patients newly diagnosed with lymphoma and myeloma
10.1182/bloodadvances.2024014821 · 2025 · External reference
The course of anxiety and depression for patients with Hodgkin’s lymphoma or diffuse large B cell lymphoma: A longitudinal study of the PROFILES registry
10.1007/s11764-014-0367-1 · 2014 · External reference
Depression and anxiety in patients with hematological malignancies, prevalence, and associated factors
10.15537/smj.2016.8.14597 · 2016 · External reference
Prevalence of anxiety, depression, and distress and their association with problems encountered by advanced cancer patients in a tertiary hospital in Saudi Arabia
2024 · External reference
Prevalence of depression and anxiety among newly diagnosed cancer patients: A single centre experience in the Middle East
10.3332/ecancer.2024.1690 · 2024 · External reference
Prevalence of depression and anxiety symptoms among patients with cancer in Najran, Saudi Arabia
2024 · External reference
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
10.1016/s0140-6736(07)61602-x · 2007 · External reference
The PHQ-9: Validity of a brief depression severity measure
10.1046/j.1525-1497.2001.016009606.x · 2001 · External reference
The Hospital Anxiety and Depression Scale (HADS) and the 9-item patient health questionnaire (PHQ-9) as screening instruments for depression in patients with cancer
10.1002/cncr.30846 · 2017 · External reference
A brief measure for assessing generalized anxiety disorder: The GAD-7
10.1001/archinte.166.10.1092 · 2006 · External reference
The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients
10.1002/pon.4681 · 2018 · External reference
Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation
10.1200/jco.2013.52.4611 · 2014 · External reference
A brief measure for assessing generalized anxiety disorder: The GAD-7
10.1001/archinte.166.10.1092 · ExternalCitation · doi-reference
The Hospital Anxiety and Depression Scale (HADS) and the 9-item patient health questionnaire (PHQ-9) as screening instruments for depression in patients with cancer
10.1002/cncr.30846 · ExternalCitation · doi-reference
The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients
10.1002/pon.4681 · ExternalCitation · doi-reference
The course of anxiety and depression for patients with Hodgkin’s lymphoma or diffuse large B cell lymphoma: A longitudinal study of the PROFILES registry
10.1007/s11764-014-0367-1 · ExternalCitation · doi-reference
Anxiety and depression in adult cancer patients: ESMO clinical practice guideline
10.1016/j.esmoop.2023.101155 · ExternalCitation · doi-reference
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
10.1016/s0140-6736(07)61602-x · ExternalCitation · doi-reference
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies
10.1016/s1470-2045(11)70002-x · ExternalCitation · doi-reference
The PHQ-9: Validity of a brief depression severity measure
10.1046/j.1525-1497.2001.016009606.x · ExternalCitation · doi-reference
Anxiety and depression among patients newly diagnosed with lymphoma and myeloma
10.1182/bloodadvances.2024014821 · ExternalCitation · doi-reference
Global prevalence and determinant factors of pain, depression, and anxiety among cancer patients: An umbrella review of systematic reviews and meta-analyses
10.1186/s12888-025-06599-5 · ExternalCitation · doi-reference
Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation
10.1200/jco.2013.52.4611 · ExternalCitation · doi-reference
Depression and anxiety in patients with hematological malignancies, prevalence, and associated factors
10.15537/smj.2016.8.14597 · ExternalCitation · doi-reference
Prevalence of depression and anxiety among newly diagnosed cancer patients: A single centre experience in the Middle East
10.3332/ecancer.2024.1690 · ExternalCitation · doi-reference
